UM

Browse/Search Results:  1-7 of 7 Help

Selected(0)Clear Items/Page:    Sort:
Nitric Oxide and Immune Responses in Cancer: Searching for New Therapeutic Strategies Review article
2021
Authors:  Sahebnasagh, Adeleh;  Saghafi, Fatemeh;  Negintaji, Sina;  Hu, Tingyan;  Shabani-Borujeni, Mojtaba; et al.
Favorite | TC[WOS]:19 TC[Scopus]:19  IF:3.5/4.0 | Submit date:2022/05/13
Cancer  Enos  Immunity  Inos  Nitric Oxide  Nnos  Pleiotropic Signaling  
Dietary polyphenols for managing cancers: What have we ignored? Review article
2020
Authors:  Xu Wu;  Mingxing Li;  Zhangang Xiao;  Maria Daglia;  Simona Dragane; et al.
Favorite | TC[WOS]:35 TC[Scopus]:37  IF:15.1/16.4 | Submit date:2021/03/02
Anti-cancer Activity  Bioavailability  Dietary Polyphenols  Metabolites  Microbiota  Stability  
Flavonoid biosynthetic pathways in plants: Versatile targets for metabolic engineering Review article
2020
Authors:  Seyed Mohammad Nabavi ;  Dunja Šamec;  Michał Tomczyk;  Luigi Milella;  Daniela Russo; et al.
Favorite | TC[WOS]:348 TC[Scopus]:393  IF:12.1/14.6 | Submit date:2021/12/03
Acetate  Flavonoids  Metabolic Engineering  Shikimic Acid  
Antidepressive effects of a chemically characterized maqui berry extract (Aristotelia chilensis (molina) stuntz) in a mouse model of Post-stroke depression Conference paper
Arianna Di Lorenzo, Anatoly P. Sobolev, Seyed Fazel Nabavi, Antoni Sureda, Akbar Hajizadeh Moghaddam, Sedigheh Khanjani, Carmen Di Giovanni, Jianbo Xiao, Samira Shirooie, Arold Jorel Tsetegho Sokeng, Alessandra Baldi, Luisa Mannina, Seyed Mohammad Nabavi, Maria Daglia. Antidepressive effects of a chemically characterized maqui berry extract (Aristotelia chilensis (molina) stuntz) in a mouse model of Post-stroke depression[C], 2019, 434-443.
Authors:  Arianna Di Lorenzo;  Anatoly P. Sobolev;  Seyed Fazel Nabavi;  Antoni Sureda;  Akbar Hajizadeh Moghaddam; et al.
Favorite | TC[WOS]:26 TC[Scopus]:31 | Submit date:2020/04/24
Chemical Characterization  In Vivo Antioxidant Activity  Maqui Berry Extract  Murine Model System  Post-stroke Depression  
Antidepressive effects of a chemically characterized maqui berry extract (Aristotelia chilensis (molina) stuntz) in a mouse model of Post-stroke depression Journal article
Di Lorenzo, Arianna, Sobolev, Anatoly P., Nabavi, Seyed Fazel, Sureda, Antoni, Moghaddam, Akbar Hajizadeh, Khanjani, Sedigheh, Di Giovanni, Carmen, Xiao, Jianbo, Shirooie, Samira, Tsetegho Sokeng, Arold Jorel, Baldi, Alessandra, Mannina, Luisa, Nabavi, Seyed Mohammad, Daglia, Maria. Antidepressive effects of a chemically characterized maqui berry extract (Aristotelia chilensis (molina) stuntz) in a mouse model of Post-stroke depression[J]. Food and Chemical Toxicology, 2019, 129, 434-443.
Authors:  Di Lorenzo, Arianna;  Sobolev, Anatoly P.;  Nabavi, Seyed Fazel;  Sureda, Antoni;  Moghaddam, Akbar Hajizadeh; et al.
Favorite | TC[WOS]:26 TC[Scopus]:31  IF:3.9/4.5 | Submit date:2022/05/17
Chemical Characterization  In Vivo Antioxidant Activity  Maqui Berry Extract  Murine Model System  Post-stroke Depression  
Anti-inflammatory effects of Melatonin: A mechanistic review Review article
2019
Authors:  Nabavi, Seyed Mohammad;  Nabavi, Seyed Fazel;  Sureda, Antoni;  Xiao, Janbo;  Dehpour, Ahmad Reza; et al.
Favorite | TC[WOS]:87 TC[Scopus]:119  IF:7.3/10.3 | Submit date:2022/05/23
Chronic Inflammation  Nuclear Factor Kappa-b  Oxidative Stress  Pro-inflammatory Markers  
Evidence and prospective of plant derived flavonoids as antiplatelet agents: Strong candidates to be drugs of future Conference paper
Khan, Harron, Jawad, Mohammad, Kamal, Mohammad Amjad, Baldi, Alessandra, Xiao, Jianbo, Nabavi, Seyed Mohammad, Daglia, Maria. Evidence and prospective of plant derived flavonoids as antiplatelet agents: Strong candidates to be drugs of future[C], THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND:PERGAMON-ELSEVIER SCIENCE LTD, 2018, 355-367.
Authors:  Khan, Harron;  Jawad, Mohammad;  Kamal, Mohammad Amjad;  Baldi, Alessandra;  Xiao, Jianbo; et al.
Favorite | TC[WOS]:67 TC[Scopus]:77 | Submit date:2018/10/30
Antiplatelet  Preclinical Studies  Structure-activity Relationship (Sar) Studies  Pharmacokinetic Parameters  Safety Profile